Literature DB >> 8439228

The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration.

M R Lebowitz1, S A Blumenthal.   

Abstract

After beta-cell stimulation by carbohydrate or other secretagogues, insulin and C-peptide are secreted into the portal vein in a 1:1 molar ratio. A large fraction of endogenous insulin is cleared by the liver, whereas C-peptide, which is cleared primarily by the kidney and has a lower metabolic clearance rate than insulin, traverses the liver with essentially no extraction by hepatocytes. Hence, the molar ratio of insulin to C-peptide in peripheral venous blood (ICPR) should be less than 1.0 during fasting and feeding, unless exogenous insulin is introduced into the systemic circulation. Consequently, an ICPR in excess of 1.0 in a hypoglycemic patient argues persuasively for surreptitious or inadvertent insulin administration and against insulinoma (or sulfonylurea ingestion) as the cause of the hypoglycemia. This conclusion is supported by personal experience and by the literature.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439228

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  22 in total

1.  Disorders of glucose metabolism: post mortem analyses in forensic cases--part II.

Authors:  Frank Musshoff; Cornelius Hess; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-10-07       Impact factor: 2.686

2.  Case files of the Harvard Medical Toxicology Fellowship at Children's Hospital Boston: an insulin overdose.

Authors:  Aaron Benjamin Skolnik; Michele Burns Ewald
Journal:  J Med Toxicol       Date:  2010-12

Review 3.  Disorders of glucose metabolism-post mortem analyses in forensic cases: part I.

Authors:  Cornelius Hess; Frank Musshoff; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-09-29       Impact factor: 2.686

4.  Enhanced insulin clearance in mice lacking TRPM8 channels.

Authors:  Daniel D McCoy; Ligang Zhou; Anh-Khoi Nguyen; Alan G Watts; Casey M Donovan; David D McKemy
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

Review 5.  Diagnosis and management of insulinoma.

Authors:  Takehiro Okabayashi; Yasuo Shima; Tatsuaki Sumiyoshi; Akihito Kozuki; Satoshi Ito; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

6.  Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin.

Authors:  Jill K Morris; Eric D Vidoni; Jonathan D Mahnken; Robert N Montgomery; David K Johnson; John P Thyfault; Jeffrey M Burns
Journal:  Neurobiol Aging       Date:  2015-12-01       Impact factor: 4.673

Review 7.  Factitious hypoglycemia in children and adolescents with diabetes.

Authors:  Viviana Bauman; Adaya C Sturkey; Rosa Sherafat-Kazemzadeh; Jennifer McEwan; Paul M Jones; Ashley Keating; Elvira Isganaitis; Alyne Ricker; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2018-02-21       Impact factor: 4.866

Review 8.  Clinical and Laboratory Aspects of Insulin Autoantibody-Mediated Glycaemic Dysregulation and Hyperinsulinaemic Hypoglycaemia: Insulin Autoimmune Syndrome and Exogenous Insulin Antibody Syndrome.

Authors:  Tony Huynh
Journal:  Clin Biochem Rev       Date:  2020-12

9.  Quantile contours and allometric modelling for risk classification of abnormal ratios with an application to asymmetric growth-restriction in preterm infants.

Authors:  Marco Geraci; Nansi S Boghossian; Alessio Farcomeni; Jeffrey D Horbar
Journal:  Stat Methods Med Res       Date:  2019-09-23       Impact factor: 3.021

Review 10.  Insulin autoimmune syndrome: from diagnosis to clinical management.

Authors:  Simona Censi; Caterina Mian; Corrado Betterle
Journal:  Ann Transl Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.